Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Share-based Compensation (2020 - 2021)

Historic Share-based Compensation for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to $1.6 million.

  • Design Therapeutics' Share-based Compensation rose 26959.62% to $1.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.7 million, marking a year-over-year increase of 94200.0%. This contributed to the annual value of $13.1 million for FY2024, which is 12.22% down from last year.
  • As of Q4 2021, Design Therapeutics' Share-based Compensation stood at $1.6 million, which was up 26959.62% from $1.2 million recorded in Q3 2021.
  • In the past 5 years, Design Therapeutics' Share-based Compensation ranged from a high of $1.6 million in Q4 2021 and a low of $4000.0 during Q1 2020